文献速递精神分裂症与精神病性障碍

首发精神病中皮质谷氨酸与纹状体多巴胺合成能力的关系:横断面多模态PET与磁共振波谱成像研究

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
PubMed 文献 · Lancet Psychiatry · 2018-09-17

该横断面多模态影像研究纳入28例首发精神病患者和28名健康对照,采用18F-DOPA PET测量纹状体多巴胺合成能力、质子磁共振波谱测量前扣带回皮质谷氨酸浓度。

要点

  • 首发精神病患者中前扣带回谷氨酸浓度与纹状体多巴胺合成能力呈显著负相关。
  • 健康对照中谷氨酸与多巴胺指标无显著关系,阳性症状与多巴胺正相关、与谷氨酸负相关。

核心结论

  • 观察结果与「皮质谷氨酸功能异常与皮质下多巴胺合成能力及精神病相关」的假说一致。
  • 皮质谷氨酸与多巴胺在体内的确切机制关系仍不清楚,但支持进一步研究调节皮质谷氨酸治疗精神病的效果。

研究设计与样本

  • 横断面多模态影像研究,纳入28例首发精神病患者和28名健康对照。
  • 患者来自英国伦敦首发精神病服务机构,要求处于精神病首次发作且无既往疾病或治疗史。
  • 所有参与者排除标准包括:严重头部外伤史、违禁物质依赖、医学共病(轻微疾病除外)及扫描禁忌(如妊娠)。
  • 采用18F-DOPA PET测量纹状体多巴胺合成能力,质子磁共振波谱测量前扣带回皮质谷氨酸浓度。
  • 主要终点为患者中前扣带回谷氨酸浓度与纹状体多巴胺合成能力的关系,采用线性回归分析。

临床怎么用

  • 结果提示皮质谷氨酸功能异常可能与皮质下多巴胺合成能力及精神病症状相关,为调节皮质谷氨酸治疗精神病的研究提供依据。
  • 目前尚不能据此改变临床实践,皮质谷氨酸与多巴胺在体内的确切机制关系仍不清楚。

局限性

  • 横断面设计无法确定皮质谷氨酸与多巴胺之间的因果方向。
  • 样本量较小(28例患者和28名对照),结果需在更大样本中验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The pathophysiology of psychosis is incompletely understood. Disruption in cortical glutamatergic signalling causing aberrant striatal dopamine synthesis capacity is a proposed model for psychosis, but has not been tested in vivo. We therefore aimed to test the relationship between cortical glutamate concentrations and striatal dopamine synthesis capacity, and psychotic symptoms. METHODS: In this cross-sectional multimodal imaging study, 28 individuals with first-episode psychosis and 28 healthy controls underwent 18F-DOPA PET (measuring striatal dopamine synthesis capacity), and proton magnetic resonance spectroscopy (measuring anterior cingulate cortex glutamate concentrations). Participants were recruited from first-episode psychosis services in London, UK and were required to be in the first episode of a psychotic illness, with no previous illness or treatment episodes. Exclusion criteria for all participants were: history of substantial head trauma, dependence on illicit substances, medical comorbidity (other than minor illnesses), and contraindications to scanning (such as pregnancy). Symptoms were measured using the Positive and Negative Syndrome Scale. The primary endpoint was the relationship between anterior cingulate cortex glutamate concentrations and striatal dopamine synthesis capacity in individuals with their first episode of psychosis as shown by imaging, examined by linear regression. Linear regression was used to examine relationships between measures. FINDINGS: Glutamate concentrations showed a significant inverse relationship with striatal dopamine synthesis capacity in patients with psychosis (R2=0·16, p=0·03, β -1·71 × 10-4, SE 0·76 × 10-4). This relationship remained significant after the addition of age, gender, ethnicity, and medication status to the model (p=0·015). In healthy controls, there was no significant relationship between dopamine and glutamate measures (R2=0·04, p=0·39). Positive and Negative Syndrome Scale positive psychotic symptoms were positively associated with striatal dopamine synthesis capacity (R2=0·14, p=0·046, β 2546, SE 1217) and showed an inverse relationship with anterior cingulate glutamate concentrations (R2=0·16, p=0·03, β -1·71 × 10-4, SE 7·63 × 10-5). No relationships were seen with negative symptoms (positive symptoms, mean [SD] -18·4 (6·6) negative symptoms, mean [SD] -15·4 [6·1]). INTERPRETATION: These observations are consistent with the hypothesis that cortical glutamate dysfunction is related to subcortical dopamine synthesis capacity and psychosis. Although the precise mechanistic relationship between cortical glutamate and dopamine in vivo remains unclear, our findings support further studies to test the effect of modulating cortical glutamate in the treatment of psychosis. FUNDING: Medical Research Council, Wellcome Trust, Biomedical Research Council, South London and Maudsley NHS Foundation Trust, JMAS Sim Fellowship, Royal College of Physicians (Edinburgh) (SJ).

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jauhar S, McCutcheon R, Borgan F, et al. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study. Lancet Psychiatry. 2018. PMID: 30236864. doi:10.1016/S2215-0366(18)30268-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。